Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake.
Vlachopoulos C, Koutagiar I, Skoumas I, Terentes-Printzios D, Zacharis E, Kolovou G, Stamatelopoulos K, Rallidis L, Katsiki N, Bilianou H, Liberopoulos E, Miliou A, Kafouris P, Georgakopoulos A, Gardikioti V, Tousoulis D, Anagnostopoulos CD.
Vlachopoulos C, et al. Among authors: koutagiar i.
JACC Cardiovasc Imaging. 2019 Dec;12(12):2573-2574. doi: 10.1016/j.jcmg.2019.09.024.
JACC Cardiovasc Imaging. 2019.
PMID: 31806185
Free article.
No abstract available.